Lack of pharmacokinetic drug–drug interaction between ramucirumab and irinotecan in patients with advanced solid tumors

被引:0
|
作者
Ding Wang
Fadi Braiteh
James J. Lee
Crystal S. Denlinger
Dale R. Shepard
Archana Chaudhary
Yong Lin
Ling Gao
Christopher Asakiewicz
Federico Nasroulah
Patricia LoRusso
机构
[1] Henry Ford Hospital,
[2] Comprehensive Cancer Centers of Nevada,undefined
[3] University of Pittsburgh School of Medicine,undefined
[4] Fox Chase Cancer Center,undefined
[5] Cleveland Clinic,undefined
[6] Eli Lilly and Company,undefined
[7] Eli Lilly and Company,undefined
[8] Yale Cancer Center,undefined
来源
关键词
Pharmacokinetics; Drug–drug interactions; Ramucirumab; Irinotecan; SN-38; FOLFIRI;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:727 / 733
页数:6
相关论文
共 50 条
  • [1] Lack of pharmacokinetic drug-drug interaction between ramucirumab and irinotecan in patients with advanced solid tumors
    Wang, Ding
    Braiteh, Fadi
    Lee, James J.
    Denlinger, Crystal S.
    Shepard, Dale R.
    Chaudhary, Archana
    Lin, Yong
    Gao, Ling
    Asakiewicz, Christopher
    Nasroulah, Federico
    LoRusso, Patricia
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (04) : 727 - 733
  • [2] Lack of pharmacokinetic drug–drug interaction between ramucirumab and paclitaxel in a phase II study of patients with advanced malignant solid tumors
    Laura Q. M. Chow
    David C. Smith
    Antoinette R. Tan
    Crystal S. Denlinger
    Ding Wang
    Dale R. Shepard
    Archana Chaudhary
    Yong Lin
    Ling Gao
    Cancer Chemotherapy and Pharmacology, 2016, 78 : 433 - 441
  • [3] Lack of pharmacokinetic drug-drug interaction between ramucirumab and paclitaxel in a phase II study of patients with advanced malignant solid tumors
    Chow, Laura Q. M.
    Smith, David C.
    Tan, Antoinette R.
    Denlinger, Crystal S.
    Wang, Ding
    Shepard, Dale R.
    Chaudhary, Archana
    Lin, Yong
    Gao, Ling
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (02) : 433 - 441
  • [4] Phase 1 Pharmacokinetic and Drug-Interaction Study of Dasatinib in Patients With Advanced Solid Tumors
    Johnson, Faye M.
    Agrawal, Shruti
    Burris, Howard
    Rosen, Lee
    Dhillon, Navneet
    Hong, David
    Blackwood-Chirchir, Anne
    Luo, Feng R.
    Sy, Oumar
    Kaul, Sanjeev
    Chiappori, Alberto A.
    CANCER, 2010, 116 (06) : 1582 - 1591
  • [5] Lack of pharmacokinetic drug-drug interaction between orlistat and cerivastatin
    Mück W.
    Adelmann H.-G.
    Ruf T.
    Unger S.
    Voith B.
    Clinical Drug Investigation, 2000, 19 (1) : 71 - 73
  • [6] Lack of pharmacokinetic drug-drug interaction between ciclesonide and erythromycin
    Nave, R
    Drollmann, A
    Steinijans, VW
    Zech, K
    Bethke, TD
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2005, 43 (06) : 264 - 270
  • [7] Lack of pharmacokinetic drug-drug interaction between orlistat and cerivastatin
    Mück, W
    Adelmann, HG
    Ruf, T
    Unger, S
    Voith, B
    CLINICAL DRUG INVESTIGATION, 2000, 19 (01) : 71 - 73
  • [8] Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumors
    Crystal S. Denlinger
    Rebecca Blanchard
    Lu Xu
    Coen Bernaards
    Samuel Litwin
    Cynthia Spittle
    Daniel J. Berg
    Susan McLaughlin
    Maryann Redlinger
    Andrew Dorr
    Julie Hambleton
    Scott Holden
    Anne Kearns
    Sara Kenkare-Mitra
    Bert Lum
    Neal J. Meropol
    Peter J. O’Dwyer
    Cancer Chemotherapy and Pharmacology, 2009, 65 : 97 - 105
  • [9] Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumors
    Denlinger, Crystal S.
    Blanchard, Rebecca
    Xu, Lu
    Bernaards, Coen
    Litwin, Samuel
    Spittle, Cynthia
    Berg, Daniel J.
    McLaughlin, Susan
    Redlinger, Maryann
    Dorr, Andrew
    Hambleton, Julie
    Holden, Scott
    Kearns, Anne
    Kenkare-Mitra, Sara
    Lum, Bert
    Meropol, Neal J.
    O'Dwyer, Peter J.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 65 (01) : 97 - 105
  • [10] LACK OF PHARMACOKINETIC DRUG- DRUG INTERACTION BETWEEN BEMNIFOSBUVIR AND RUZASVIR IN HEALTHY PARTICIPANTS
    Zhou, Xiao-Jian
    Morelli, Gaetano
    Montrond, Maureen
    Lynch, Shannan
    Pietropaolo, Keith
    Belanger, Bruce
    Horga, Arantxa
    Hammond, Janet
    HEPATOLOGY, 2023, 78 : S727 - S728